Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium.
Rocq
Nicolas
N
Pôle Anesthésie-Réanimation, Centre Hospitalier Universitaire, Nancy, France. rocq.nicolas@gmail.com
Favier
Jean-Christophe
JC
Plancade
David
D
Steiner
Thierry
T
Mertes
Paul-Michel
PM
D000707:Anaphylaxis / Q000503:physiopathology* / Q000628:therapy; D000768:Anesthesia, General; D016887:Cardiopulmonary Resuscitation; D004351:Drug Resistance; D004837:Epinephrine / Q000627:therapeutic use*; D006323:Heart Arrest / Q000628:therapy*; D006552:Hernia, Inguinal / Q000601:surgery; D006801:Humans; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D013390:Succinylcholine / Q000009:adverse effects*; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D009467:Neuromuscular Depolarizing Agents; D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin; D013390:Succinylcholine; D004837:Epinephrine